Publication | Open Access
Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology
22
Citations
9
References
2019
Year
This study demonstrates that the tofacitinib ECS osmotic tablet platform can achieve a Level A IVIVC, similar to other osmotic delivery systems.
| Year | Citations | |
|---|---|---|
Page 1
Page 1